(BiC/4-AP). Mean ± s.e.m. shown. B) Neurons were treated and studied exactly as in Fig. 6c except that they were transfected with a non-tagged, cytoplasmic form of GCaMP2. *p<0.05 
Transfection and nucleofection
Neurons were transfected in trophic transfection medium 55 with plasmids (2µg/ml total) and/or siRNA (100nM) using Lipofectamine 2000. The sequence targeted by Mcu-directed siRNA is cgaccuagagaaauacaau; control siRNA used was siGENOME Non-Targeting siRNA 2 (Dharmacon). Experiments were performed 48h post-transfection. Nucleofection was performed using the Amaxa rat Neuron Nucleofector Kit (Lonza). Briefly, for every sample, mouse cortical neuron pellets containing 4-5 x 10 6 cells were mixed with 100l nucleofector solution and either 3g plasmid DNA or 300mol siRNA. Nucleofection was carried out using a Nucleofector II system. Following nucleofection, 50l pre-equilibrated Opti-MEM was added to each sample and the cells gently plated down in 24-well dish. Nucleofection efficiency was determined by eGFP expression 48 h after transfection and was routinely 50%-60%.
Plasmids and virus generation
The vector containing the mouse CaMKIIα promoter used to construct and package recombinant adeno-associated virus (rAAV) has been described previously 
Studying transfected neurons after excitotoxic insult:
Excitotoxicity experiments performed on Lipofectamine-transfected neurons were performed as described 45, 59 . Neurons were transfected with the plasmid or siRNA of interest (or control) plus eGFP marker. To apply an excitotoxic insult, neurons were first placed overnight into a minimal defined medium 33, 45 . Pictures were then taken using a Leica AF6000LX system (DFC350 FX camera) prior to NMDA treatment for 1 h, after which 10 µM MK-801 was added. Using cellfinder software, images of the same neurons were taken 24 h post-insult. Cell death was determined by counting the number of surviving GFP-expressing cells post-insult. Death was indentified by the absence of healthy GFP-expressing neurons: in >90% of cases fluorescent cell debris and fragmented nuclei were observed. For each condition, the fate of 300-600 neurons was monitored over n=4-6 experiments done on independent cultures. The induction and analysis of NMDA-induced neuronal cell death of rAAV-infected neurons was done as described 60 with slight changes. Briefly, neurons were treated with NMDA with different concentrations for 10 min at 37°C, washed three times with transfection medium 55 and incubated at 37°C for 20 h. The percentage of dead cells was determined by analyzing Hoechst 33258 stained nuclei.
In the case of Mcu-over-expressing neurons, we found that this increased basal levels of death (in the absence of NMDA exposure). In addition to showing the raw cell death data ( Fig. 3) , we also calculated whether Mcu overexpression specifically rendered neurons more vulnerable to NMDA exposure, taking into account this increased basal death ( Supplementary   Fig. S2 ). The chances of a neuron surviving an NMDA insult in the presence or absence of Mcu expression can be expressed according to the equation: P SURVIVAL = (1-P BASAL ) x (1-P NMDA ), where P BASAL is the probability of a neuron dying in the absence of any NMDA, and P NMDA is the probability of a cell dying due to the NMDA insult. A value for P NMDA can be calculated because we know the other variables in the equation (we know P SURVIVAL from the cell death data and P BASAL from the cell death % in the absence of NMDA). City, CA, USA). Total RNA was extracted using RNeasy kit (Qiagen GmbH, Germany) with additional on-column DNase I digestion during RNA purification. cDNA was generated from 1 μg of total RNA using High Capacity cDNA Reverse Transcription kit (Applied Biosystems).
Quantitative reverse transcriptase PCR
QRT-PCR was carried out using TaqMan Universal PCR Master Mix (Applied Biosystems). The following TaqMan gene expression assays were used in this study: Mcu (Mm01168773_m1), gusb (Mm00446953_m1), Npas4 (Mm00463644_m1), 18 s rRNA (4319413E). The expression levels of the target mRNA were normalized to the relative ratio of the expression of Gusb or 18 s rRNA as endogenous control.
